Marijuana stock Curaleaf (OTC: CURLF) didn't get a lot of investors high Monday, despite delivering better-than-expected revenue for its inaugural quarter of 2021. For the marijuana company's first quarter, the figures for which were published that morning, it booked $260 million in revenue, 170% higher on a year-over-year basis and 13% better than the fourth-quarter 2020 number. It was also a new all-time Q1 record for Curaleaf. The multi-state operator's (MSO) net loss was $17.2 million, or $0.03 per share. That was slightly worse than the Q1 2020 deficit of just over $15 million, but a big improvement over the previous quarter's $35.1 million shortfall. On the marijuana industry's preferred profitability metric -- non-GAAP (adjusted) EBITDA -- Curaleaf earned $62.6 million, against the year-ago result of $20 million and Q4's $53.8 million. Image source: Getty Images. On average, analysts tracking the stock were expecting only $254 million in revenue; however, they thought the company would post a net loss of $0.01 per share. But Curaleaf has a keen eye trained on the future. The company quoted its CEO Boris Jordan as pointing out that "The recent approvals of adult-use cannabis in New Jersey and New York, which are states where Curaleaf has a leading market share, will unlock vast new markets, worth an estimated $2.1 billion and $5 billion in sales, respectively." Investors, however, might be more concerned that a giant competitor for Curaleaf is about to arise. Monday morning, Trulieve Cannabis (OTC: TCNNF) and Harvest Health & Recreation (OTC: HRVSF) announced the former is acquiring the latter in a (relatively) massive $2.1 billion all-stock deal. The combined company will have 126 dispensaries under its wing, eclipsing Curaleaf's tally of 106. This was likely the driving factor in Curaleaf stock's 4.3% fall Monday, against the S&P 500's decrease of only 1%. 10 stocks we like better than Curaleaf Holdings, Inc.When investing geniuses David and Tom Gardner have a stock tip, it can pay to listen. After all, the newsletter they have run for over a decade, Motley Fool Stock Advisor, has tripled the market.* David and Tom just revealed what they believe are the ten best stocks for investors to buy right now... and Curaleaf Holdings, Inc. wasn't one of them! That's right -- they think these 10 stocks are even better buys. See the 10 stocks *Stock Advisor returns as of February 24, 2021 Eric Volkman has no position in any of the stocks mentioned. The Motley Fool owns shares of and recommends Trulieve Cannabis Corp. The Motley Fool has a disclosure policy.Source